Clinical trials
Completed Phase 1 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| Acrotech Biopharma Inc. | 2 |
| Case Comprehensive Cancer Center | 2 |
| Solasia Pharma K.K. | 2 |
| Amir Mortazavi | 1 |
| Boryung Pharmaceutical Co., Ltd | 1 |
| Canadian Cancer Trials Group | 1 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 43 |
| Lymphoma, T-Cell, Cutaneous | 19 |
| Lymphoma, Extranodal NK-T-Cell | 17 |
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Lymphoma, Large-Cell, Anaplastic | 15 |
| Hodgkin Disease | 14 |
| Immunoblastic Lymphadenopathy | 14 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 13 |
| Lymphoma, B-Cell, Marginal Zone | 13 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.